Brief: India's Suven Life Sciences Gets Product Patent In Canada
April 3 (Reuters) - Suven Life Sciences Ltd SUVP.NS :
* GETS PRODUCT PATENT IN CANADA
* PATENT CORRESPONDING TO NEW CHEMICAL ENTITY FOR TREATMENT
OF
DISORDERS ASSOCIATED WITH NEURODEGENERATIVE DISEASES
* PATENT IS VALID THROUGH 2033
Source text - https://bit.ly/2pZFzag
Further company coverage: SUVP.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Suven Life Sciences
See all newsBrief: Suven Life Sciences Completes Patient Enrollment In Global Phase-3 Masupirdine Study
India's Suven Life Sciences gains after Masupirdine Phase-3 study completes patient enrollment
Brief: Suven Life Sciences Completes Phase-1 Study Of SUVN-I6107, Advances To Phase-2
Brief: Suven Life Sciences Reports Positive DSMB Safety Review For Phase-3 Masupirdine Study
Brief: Suven Life Sciences Records 100% Patient Enrolment Milestone In Phase-2B Clinical Trial Of Ropanicant